10-Q: FitLife Brands Reports Strong Q2 2024 Results Driven by Acquisitions and Online Growth

FitLife Brands saw a significant increase in revenue and net income in Q2 2024, primarily driven by recent acquisitions and growth in online sales.

Summary

• FitLife Brands reported a 15% increase in revenue for the three months ended June 30, 2024, reaching $16.93 million, compared to $14.76 million in the same period last year.
• The company's net income for the quarter was $2.63 million, a 34% increase from $1.96 million in Q2 2023.
• For the six months ended June 30, 2024, revenue increased by 31% to $33.48 million, compared to $25.50 million in the first half of 2023.
• Net income for the first half of 2024 was $4.79 million, a 126% increase from $2.12 million in the same period last year.
• The increase in revenue is primarily attributed to the acquisitions of Mimis Rock Corp (MRC) and MusclePharm assets, with online sales contributing a significant portion of the growth.
• Online revenue accounted for approximately 66% of total net revenue for both the three and six months ended June 30, 2024.
• Gross margin improved to 44.8% in Q2 2024, up from 40.4% in Q2 2023, due to higher margins from MRC and the amortization of the fair value step-up to MRC inventory.
• The company's operating income for the three months ended June 30, 2024 was $3.68 million, a 42% increase from $2.58 million in the same period last year.
• The company's operating income for the six months ended June 30, 2024 was $7.06 million, a 117% increase from $3.26 million in the same period last year.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, driven by strategic acquisitions and online sales growth. While there are some challenges, the overall tone is optimistic and indicates a healthy trajectory for the company.

Positives

• The company experienced significant revenue growth due to the acquisition of MusclePharm and the full period impact of MRC.
• Net income increased substantially for both the quarter and the six-month period.
• Gross margin improved, indicating better profitability on sales.
• Online sales continue to be a strong driver of revenue.
• The company is successfully optimizing advertising spend and reducing less effective campaigns.
• The company is in compliance with all debt covenants.
• The company has a strong cash position and positive working capital.

Negatives

• Legacy FitLife revenue declined by 5% in Q2 2024, driven by a decrease in wholesale revenue.
• MRC revenue decreased by 2% in Q2 2024.
• SG&A expenses increased due to product testing costs, professional fees, and headcount additions.
• MusclePharm's gross margin and contribution margin declined as a percentage of revenue due to increased advertising and promotion investments.

Risks

• The company's wholesale revenue continues to be challenged by declining customer counts in brick-and-mortar stores.
• The company is dependent on cash flow from operations and amounts available under the Line of Credit to satisfy its working capital requirements.
• There is no assurance that cash flow from operations and/or the Line of Credit will be sufficient to provide for the company's liquidity for the next twelve months.
• The company's stock price experiencing significant price fluctuations could impact the fair value of the reporting unit, which can lead to potential impairment in future periods.
• The company has exposure to fluctuations in foreign currencies due to the MRC acquisition.

Future Outlook

Management believes that online revenue will continue to increase in subsequent periods given the focus on higher margin online sales and the acquisition of the MusclePharm assets. The company anticipates that cash derived from operations and existing cash reserves, along with available borrowings under the Line of Credit, will be sufficient to provide for the company's liquidity for the next twelve months.

Management Comments

• Management believes that contribution, as defined by the Company, is a particularly relevant performance metric since it incorporates the gross profit associated with a specific brand or collection of brands as well as the advertising and marketing expenditures associated with the same brand or brands.
• Management intends to provide this level of disclosure for no more than two years following a transaction, after which the performance of acquired brands will be reported as part of legacy FitLife results.
• Management currently has no intention to raise additional working capital through the sale of equity or debt securities and believes that the cash flow from operations and available borrowings under the Line of Credit will provide sufficient capital necessary to operate the business over the next twelve months.

Industry Context

The company's performance reflects a broader trend in the nutritional supplement industry, with a growing emphasis on online sales and strategic acquisitions to expand product offerings and market reach. The company's focus on higher margin online sales aligns with the industry's shift towards e-commerce.

Comparison to Industry Standards

• FitLife Brands' gross margin of 44.8% in Q2 2024 is competitive with other companies in the nutritional supplement industry, such as Herbalife (around 78% gross margin) and Nu Skin (around 75% gross margin), although these companies have different business models and product mixes.
• The company's online sales growth is in line with the industry trend of increasing e-commerce adoption, with companies like Amazon and iHerb also experiencing significant growth in online sales of health and wellness products.
• The company's acquisition strategy is similar to other players in the industry, such as Nestle Health Science and The Bountiful Company, which have also grown through strategic acquisitions.
• FitLife Brands' focus on contribution margin as a key performance indicator is a common practice in the consumer goods industry, where companies often evaluate the profitability of individual brands or product lines.

Stakeholder Impact

• Shareholders will benefit from the increased revenue, net income, and improved profitability.
• Employees may see increased job security and potential for growth due to the company's positive performance.
• Customers will have access to a wider range of products due to the acquisitions.
• Suppliers may see increased demand for their products due to the company's growth.
• Creditors will have increased confidence in the company's ability to repay its debts due to its improved financial performance.

Next Steps

• The company will continue to focus on higher margin online sales.
• The company will continue to explore additional new product launches.
• The company will continue to have productive discussions with a number of potential new wholesale partners.
• The company will perform its next goodwill impairment analysis in December 2024.

Key Dates

Keywords

nutritional supplements, wellness products, online sales, acquisitions, revenue growth, net income, gross margin, EBITDA, MusclePharm, Mimis Rock Corp, FitLife Brands